360 related articles for article (PubMed ID: 26810071)
1. Updated TDP-43 in Alzheimer's disease staging scheme.
Josephs KA; Murray ME; Whitwell JL; Tosakulwong N; Weigand SD; Petrucelli L; Liesinger AM; Petersen RC; Parisi JE; Dickson DW
Acta Neuropathol; 2016 Apr; 131(4):571-85. PubMed ID: 26810071
[TBL] [Abstract][Full Text] [Related]
2. Staging TDP-43 pathology in Alzheimer's disease.
Josephs KA; Murray ME; Whitwell JL; Parisi JE; Petrucelli L; Jack CR; Petersen RC; Dickson DW
Acta Neuropathol; 2014 Mar; 127(3):441-50. PubMed ID: 24240737
[TBL] [Abstract][Full Text] [Related]
3. TDP-43 pathology in anterior temporal pole cortex in aging and Alzheimer's disease.
Nag S; Yu L; Boyle PA; Leurgans SE; Bennett DA; Schneider JA
Acta Neuropathol Commun; 2018 May; 6(1):33. PubMed ID: 29716643
[TBL] [Abstract][Full Text] [Related]
4. Pathological, imaging and genetic characteristics support the existence of distinct TDP-43 types in non-FTLD brains.
Josephs KA; Murray ME; Tosakulwong N; Weigand SD; Serie AM; Perkerson RB; Matchett BJ; Jack CR; Knopman DS; Petersen RC; Parisi JE; Petrucelli L; Baker M; Rademakers R; Whitwell JL; Dickson DW
Acta Neuropathol; 2019 Feb; 137(2):227-238. PubMed ID: 30604226
[TBL] [Abstract][Full Text] [Related]
5. Protein contributions to brain atrophy acceleration in Alzheimer's disease and primary age-related tauopathy.
Josephs KA; Martin PR; Weigand SD; Tosakulwong N; Buciuc M; Murray ME; Petrucelli L; Senjem ML; Spychalla AJ; Knopman DS; Boeve BF; Petersen RC; Parisi JE; Dickson DW; Jack CR; Whitwell JL
Brain; 2020 Dec; 143(11):3463-3476. PubMed ID: 33150361
[TBL] [Abstract][Full Text] [Related]
6. TDP-43 stage, mixed pathologies, and clinical Alzheimer's-type dementia.
James BD; Wilson RS; Boyle PA; Trojanowski JQ; Bennett DA; Schneider JA
Brain; 2016 Nov; 139(11):2983-2993. PubMed ID: 27694152
[TBL] [Abstract][Full Text] [Related]
7. TDP-43 and Alzheimer's Disease Pathologic Subtype in Non-Amnestic Alzheimer's Disease Dementia.
Sahoo A; Bejanin A; Murray ME; Tosakulwong N; Weigand SD; Serie AM; Senjem ML; Machulda MM; Parisi JE; Boeve BF; Knopman DS; Petersen RC; Dickson DW; Whitwell JL; Josephs KA
J Alzheimers Dis; 2018; 64(4):1227-1233. PubMed ID: 30010126
[TBL] [Abstract][Full Text] [Related]
8. Old age amyotrophic lateral sclerosis and limbic TDP-43 pathology.
Murakami A; Koga S; Sekiya H; Oskarsson B; Boylan K; Petrucelli L; Josephs KA; Dickson DW
Brain Pathol; 2022 Nov; 32(6):e13100. PubMed ID: 35715944
[TBL] [Abstract][Full Text] [Related]
9. TDP-43 proteinopathies: pathological identification of brain regions differentiating clinical phenotypes.
Tan RH; Kril JJ; Fatima M; McGeachie A; McCann H; Shepherd C; Forrest SL; Affleck A; Kwok JB; Hodges JR; Kiernan MC; Halliday GM
Brain; 2015 Oct; 138(Pt 10):3110-22. PubMed ID: 26231953
[TBL] [Abstract][Full Text] [Related]
10. Dichotomous scoring of TDP-43 proteinopathy from specific brain regions in 27 academic research centers: associations with Alzheimer's disease and cerebrovascular disease pathologies.
Katsumata Y; Fardo DW; Kukull WA; Nelson PT
Acta Neuropathol Commun; 2018 Dec; 6(1):142. PubMed ID: 30567576
[TBL] [Abstract][Full Text] [Related]
11. Alterations in the ryanodine receptor calcium release channel correlate with Alzheimer's disease neurofibrillary and beta-amyloid pathologies.
Kelliher M; Fastbom J; Cowburn RF; Bonkale W; Ohm TG; Ravid R; Sorrentino V; O'Neill C
Neuroscience; 1999; 92(2):499-513. PubMed ID: 10408600
[TBL] [Abstract][Full Text] [Related]
12. Phosphorylated TDP-43 Staging of Primary Age-Related Tauopathy.
Zhang X; Sun B; Wang X; Lu H; Shao F; Rozemuller AJM; Liang H; Liu C; Chen J; Huang M; Zhu K
Neurosci Bull; 2019 Apr; 35(2):183-192. PubMed ID: 30382507
[TBL] [Abstract][Full Text] [Related]
13. Regional distribution of TDP-43 inclusions in Alzheimer disease (AD) brains: their relation to AD common pathology.
Kadokura A; Yamazaki T; Lemere CA; Takatama M; Okamoto K
Neuropathology; 2009 Oct; 29(5):566-73. PubMed ID: 19422539
[TBL] [Abstract][Full Text] [Related]
14. Rates of hippocampal atrophy and presence of post-mortem TDP-43 in patients with Alzheimer's disease: a longitudinal retrospective study.
Josephs KA; Dickson DW; Tosakulwong N; Weigand SD; Murray ME; Petrucelli L; Liesinger AM; Senjem ML; Spychalla AJ; Knopman DS; Parisi JE; Petersen RC; Jack CR; Whitwell JL
Lancet Neurol; 2017 Nov; 16(11):917-924. PubMed ID: 28919059
[TBL] [Abstract][Full Text] [Related]
15. MRI-based basal forebrain atrophy and volumetric signatures associated with limbic TDP-43 compared to Alzheimer's disease pathology.
Teipel S; Grothe MJ;
Neurobiol Dis; 2023 May; 180():106070. PubMed ID: 36898615
[TBL] [Abstract][Full Text] [Related]
16. TAR DNA-binding protein 43 and pathological subtype of Alzheimer's disease impact clinical features.
Josephs KA; Whitwell JL; Tosakulwong N; Weigand SD; Murray ME; Liesinger AM; Petrucelli L; Senjem ML; Ivnik RJ; Parisi JE; Petersen RC; Dickson DW
Ann Neurol; 2015 Nov; 78(5):697-709. PubMed ID: 26224156
[TBL] [Abstract][Full Text] [Related]
17. Concurrence of TDP-43, tau and alpha-synuclein pathology in brains of Alzheimer's disease and dementia with Lewy bodies.
Higashi S; Iseki E; Yamamoto R; Minegishi M; Hino H; Fujisawa K; Togo T; Katsuse O; Uchikado H; Furukawa Y; Kosaka K; Arai H
Brain Res; 2007 Dec; 1184():284-94. PubMed ID: 17963732
[TBL] [Abstract][Full Text] [Related]
18. TAR DNA-binding protein 43 pathology in Alzheimer's disease with psychosis.
Vatsavayi AV; Kofler J; Demichele-Sweet MA; Murray PS; Lopez OL; Sweet RA
Int Psychogeriatr; 2014 Jun; 26(6):987-94. PubMed ID: 24588894
[TBL] [Abstract][Full Text] [Related]
19. A quantitative autoradiographic study of [3H]cAMP binding to cytosolic and particulate protein kinase A in post-mortem brain staged for Alzheimer's disease neurofibrillary changes and amyloid deposits.
Bonkale WL; Cowburn RF; Ohm TG; Bogdanovic N; Fastbom J
Brain Res; 1999 Feb; 818(2):383-96. PubMed ID: 10082824
[TBL] [Abstract][Full Text] [Related]
20. Overlapping but distinct TDP-43 and tau pathologic patterns in aged hippocampi.
Smith VD; Bachstetter AD; Ighodaro E; Roberts K; Abner EL; Fardo DW; Nelson PT
Brain Pathol; 2018 Mar; 28(2):264-273. PubMed ID: 28281308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
